124 related articles for article (PubMed ID: 17615776)
1. [Discount contracts between industry and public health insurance. Analog insulin preparations still reimbursable].
Schmidt K
MMW Fortschr Med; 2006 Nov; 148(48):60. PubMed ID: 17615776
[No Abstract] [Full Text] [Related]
2. [Health insurance discount contracts: problems and risks for the general practitioner in the medical care of patients with chronic illness].
Leutgeb R; Mahler C; Laux G; Weschnetz A; Szecsenyi J
Dtsch Med Wochenschr; 2009 Jan; 134(5):181-6. PubMed ID: 19180404
[TBL] [Abstract][Full Text] [Related]
3. [Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany].
Pruszydlo MG; Quinzler R; Kaltschmidt J; Haefeli WE
Dtsch Med Wochenschr; 2008 Jul; 133(27):1423-8. PubMed ID: 18592450
[TBL] [Abstract][Full Text] [Related]
4. [Direct purchase of expensive medicine from the manufacturer may be required].
Zimmermann GW
MMW Fortschr Med; 2015 Jun; 157(11):12. PubMed ID: 26049324
[No Abstract] [Full Text] [Related]
5. [Medication prices in Germany--how are they determined?].
Bruhn C
Dtsch Med Wochenschr; 2010 Oct; 135(39):p34. PubMed ID: 20922657
[No Abstract] [Full Text] [Related]
6. [Scope of the contract for drug therapy. Rebate contracts also for original drugs].
MMW Fortschr Med; 2009 Jul; 151(30-33):80. PubMed ID: 19722473
[No Abstract] [Full Text] [Related]
7. [New cost saving legislation for drugs. National health insurance carriers do not want to believe Ulla Schmidt}].
MMW Fortschr Med; 2006 Feb; 148(5):45. PubMed ID: 16518939
[No Abstract] [Full Text] [Related]
8. [Can physicians really save still more in drug prescriptions?].
Schmidt K
MMW Fortschr Med; 2006 Feb; 148(5):44-5. PubMed ID: 16518938
[No Abstract] [Full Text] [Related]
9. [Psychopharmacological regulations. Results and commentary to the report on drug regulations 2002].
Fritze J
Nervenarzt; 2003 Mar; 74(3):301-6. PubMed ID: 12722759
[No Abstract] [Full Text] [Related]
10. [Preventing prescription drug penalty. Advantages of cost savings].
MMW Fortschr Med; 2009 Jul; 151(30-33):81. PubMed ID: 19722474
[No Abstract] [Full Text] [Related]
11. [The physician caught between two chairs. Comments on the difficulty in dealing with off-label use].
Harder Yv
Urologe A; 2007 Oct; 46(10):1429-34. PubMed ID: 17786403
[No Abstract] [Full Text] [Related]
12. [More and more discount contracts. A chance to be free of the budget pressure].
Schmidt K
MMW Fortschr Med; 2007 May; 149(19):54-5. PubMed ID: 17668794
[No Abstract] [Full Text] [Related]
13. [Mammography--early detection--insurance coverage as IGeL service?].
Wigge P
Rofo; 2003 May; 175(5):608-12. PubMed ID: 12816079
[No Abstract] [Full Text] [Related]
14. [Bonus-penalty regulation. What is coming for us?].
Stoschek J
MMW Fortschr Med; 2006 Nov; 148(44):56-7. PubMed ID: 17619442
[No Abstract] [Full Text] [Related]
15. [Eliminating special nutrition endangers optimal nursing care].
Krankenpfl J; 2005; 43(7-10):183. PubMed ID: 16515256
[No Abstract] [Full Text] [Related]
16. [Regress for expensive medicines? When costly therapies are not a problem].
Nitz G
MMW Fortschr Med; 2013 Feb; 155(3):12. PubMed ID: 23573755
[No Abstract] [Full Text] [Related]
17. [The new drug cost saving package. Sensible measures or risk for patients?].
Krankenpfl J; 2002; 40(5-6):159. PubMed ID: 12271499
[No Abstract] [Full Text] [Related]
18. [Internists protest against drug regulation. The sanctioned physician--for the (lack of) welfare of the patient].
Thomas A
MMW Fortschr Med; 2006 Nov; 148(44):59. PubMed ID: 17619444
[No Abstract] [Full Text] [Related]
19. [The new EBM confuses family practitioners. No. 03120 not covered in chronic disease entities].
MMW Fortschr Med; 2005 May; 147(20):45-6. PubMed ID: 15957861
[No Abstract] [Full Text] [Related]
20. Easy ride for drug industry.
McBane M
Health Aff (Millwood); 2003; 22(4):259-60. PubMed ID: 12889775
[No Abstract] [Full Text] [Related]
[Next] [New Search]
